Lip 2 , Ching Hui Sia 1 , Benjamin Tan 1 1 National University of Singapore, Singapore, Singapore, 2 University of Liverpool, Liverpool, United Kingdom Background and Aims: The differential impact of atrial fibrillation detected after stroke (AFDAS) compared to known atrial fibrillation (kAF) on outcomes following thrombolysis with intravenous recombinant tissue plasminogen activator (rtPA) in ischemic stroke patients remains unclear.We aimed to evaluate the effect of AF status no AF, kAF, or AFDAS on functional and survival outcomes in ischemic stroke patients treated with thrombolysis
BPC-157 can be taken as a pill (because it remains stable in stomach acid) or via subcutaneous injection (just beneath the surface of the skin)
People choose BPC-157 peptide therapy for several key reasons: To accelerate healing from injuries To support tendon, ligament, and joint repair To reduce inflammation and discomfort To improve recovery time between workouts To support gut lining health and digestion To recover more fully from chronic or nagging injuries To return to activity with less pain or limitation To support overall tissue regeneration BPC-157 is especially appealing to individuals who want to heal smarter, faster, and more completely
Benefits of B12 injections include Increased energy levels
